Any current/future new fundraising through debt or equity?

The transcript does not mention any current or future plans for fundraising through debt or equity. There is no discussion related to new debt issuance or equity dilution in the Q&A or management commentary. The company reported a net debt position of close to Rs.900 crore (2.6 times EBITDA and 0.6 times equity) as of December 2024 but did not indicate plans to raise new funds. The focus appears to be on internal cash flow, capex completion (mostly done), and scaling existing and new business verticals. No statements indicate a need or intent to raise additional capital through debt or equity

Any current/future capex/capital investment/strategic investment?

The company has purchased a 62-acre land for future growth across different business verticals, with initial plans to put up one coating line expected to be commissioned in the next financial year. Capex for FY25 is estimated at Rs 430-450 crore, primarily allocated to the BOPP Line, CPP Line, and projects to enhance specialty sales. Majority of this capex is already done as of December 2024. A new BOPP line with a nameplate capacity of around 67,000 tons per annum is expected to be commissioned in Q1 or Q2 of FY26, which will be the world’s largest with the lowest operating cost. Specialty Ch

Future growth expectations in sales/revenue/volumes?

The company targets a top-line growth of around 20% CAGR over the next three years, aiming for approximately Rs. 2800+ crore in FY26. Commissioning of the world’s largest BOPP line in Q1 or Q2 FY26 is expected to add about 40% capacity, further accelerating sales growth. Specialty films sales are projected to increase, targeting 80% specialty volume by FY26, up from 71% YTD Dec 2024. New products in the specialty films pipeline are expected to launch in coming quarters to support growth. Specialty chemicals business is expected to grow well with new products commercializing within 3-6 months.

Future growth expectations in earnings/operating earnings/profits/EPS?

Specialty film sales expected to grow with 80% specialty volume target by FY26, potentially adding Rs.35-40 crore EBITDA from volume shift (Page 4). Specialty Chemicals segment projected to reach Rs.190 crore revenue with ~20% EBITDA margin in FY25, showing strong growth and profitability (Pages 6, 8). New BOPP and CPP lines (world’s largest capacities) to add ~40% capacity and increase production capability by 45-50%, boosting top-line growth above 20% CAGR over next 3 years (Pages 3, 4). Anticipated cost rationalization saving of Rs.25 crore in FY26, helping margin expansion (Page 3). Rigid

IN US

Sale is live|00:00:00left today

Cosmo First LtdQ4 FY26Industrial Products

Cosmo First Ltd Q4 FY26 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹822P/E: 13.7Market Cap: ₹2.0K CrSector: Industrial Products

Management growth scorecard

Revenue

Category 2

Margin

Category 1

Fundraise

N/A

Order

N/A

Capex

Yes

2 of 3 growth signals are positive.

Full analysis

Revenue guidance

Category 2

→The company targets a top-line growth of around 20% CAGR over the next three years, aiming for approximately Rs. 2800+ crore in FY26.
→Commissioning of the world’s largest BOPP line in Q1 or Q2 FY26 is expected to add about 40% capacity, further accelerating sales growth.
→Specialty films sales are projected to increase, targeting 80% specialty volume by FY26, up from 71% YTD Dec 2024.
→New products in the specialty films pipeline are expected to launch in coming quarters to support growth.
→Specialty chemicals business is expected to grow well with new products commercializing within 3-6 months.
→Rigid packaging vertical aims for over Rs. 120 crore sales with positive EBITDA in FY26.
→Sun control film and paint protection film businesses to start contributing from FY26-FY27.
→Expansion to export markets like the US and Japan will support top-line growth.

Margin guidance

Category 1

→Specialty film sales expected to grow with 80% specialty volume target by FY26, potentially adding Rs.35-40 crore EBITDA from volume shift (Page 4).
→Specialty Chemicals segment projected to reach Rs.190 crore revenue with ~20% EBITDA margin in FY25, showing strong growth and profitability (Pages 6, 8).
→New BOPP and CPP lines (world’s largest capacities) to add ~40% capacity and increase production capability by 45-50%, boosting top-line growth above 20% CAGR over next 3 years (Pages 3, 4).
→Anticipated cost rationalization saving of Rs.25 crore in FY26, helping margin expansion (Page 3).
→Rigid packaging vertical expected to exceed Rs.120 crore sales and turn EBITDA positive in FY26, contributing to profits (Page 3, 8).
→Launch of new high-margin businesses such as window films and sun control films expected to become EBITDA positive by FY27 (Pages 6, 9).
→Despite commodity margin pressures, EBITDA expected to improve due to new capacity, specialty portfolio, and cost efficiencies (Page 6).

3 more insights locked — sign up free to unlock

Fundraise plans

→The transcript does not mention any current or future plans for fundraising through debt or equity.
→There is no discussion related to new debt issuance or equity dilution in the Q&A or management commentary.
→The company reported a net debt position of close to Rs.900 crore (2.6 times EBITDA and 0.6 times equity) as of December 2024 but did not indicate plans to raise new funds.
→The focus appears to be on internal cash flow, capex completion (mostly done), and scaling existing and new business verticals.
→No statements indicate a need or intent to raise additional capital through debt or equity in the near term.

Order book

The transcript provided from the Cosmo First Limited earnings call does not contain specific information on the current or expected order book or pending orders. The conversation mainly covers topics such as: - Specialty chemical business mix and plans. - Capacity additions in BOPP and BOPET film lines. - Margin outlook and EBITDA guidance. - New product lines and expansions. - Discussions on market competition and costing advantages. - Future growth and profitability prospects of new verticals. No explicit mention or data is shared regarding order book status, order backlog, or pending orders during the call. The management also refrained from sharing detailed segmentwise confidential information publicly.

Capex plans

Yes

→The company has purchased a 62-acre land for future growth across different business verticals, with initial plans to put up one coating line expected to be commissioned in the next financial year.
→Capex for FY25 is estimated at Rs 430-450 crore, primarily allocated to the BOPP Line, CPP Line, and projects to enhance specialty sales. Majority of this capex is already done as of December 2024.
→A new BOPP line with a nameplate capacity of around 67,000 tons per annum is expected to be commissioned in Q1 or Q2 of FY26, which will be the world’s largest with the lowest operating cost.
→Specialty Chemical vertical to continue scaling up with commercialization of two new products in the next 3-6 months.
→Other new business verticals, including rigid packaging (Plastech) and sun control films, to start contributing positively to EBITDA from FY26 onwards.

How does Cosmo First Ltd rank vs peers in Industrial Products?

Pro feature

1Cosmo First Ltd

Rev 2Mar 1

See full Industrial Products sector rankings

Want more stocks like Cosmo First Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio